FDA
- Status: approved
Mesalazine with hydrocortisone sodium succinate (Mesalazine with hydrocortisone sodium succinate) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Xijing Hospital of Digestive Diseases is the originator. The local marketing authorisation holder may differ — check the official source linked above.